October 25, 2024 – Baxter just lately reported that the corporate expects to restart its highest throughput IV options manufacturing line inside the subsequent week, barring any surprising developments.

The primary batches might be manufactured concurrently with ongoing high quality actions and can solely be launched in accordance with relevant regulatory necessities to make sure the standard and security of the merchandise. It is very important be aware that the primary new North Cove merchandise can enter the distribution channel might be mid to late November. Nonetheless, that is forward of Baxter's preliminary expectations and is testomony to the urgency, dedication and resilience of the North Cove and wider Baxter groups. Baxter has been working with assist from the FDA, ASPR and HHS, and doesn’t but have a timeline for when it expects North Cove manufacturing to be absolutely restored to pre-hurricane ranges.

Proceed studying updates from Baxter.